Rigel Pharmaceuticals | RIGL - EPS Earnings Per Share


Rigel Pharmaceuticals reported $0.7 in EPS Earnings Per Share for its fiscal quarter ending in September of 2024.





Eps Change Date
Agenus USD 1.02 1.32 Mar/2026
Amgen USD 6.29 1.14 Jun/2026
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD -1.36 0.43 Jun/2026
AstraZeneca USD 2.63 0.05 Jun/2026
BioMarin Pharmaceutical USD 1.2 0.44 Jun/2026
Bristol-Myers Squibb USD 2.04 0.46 Jun/2026
Celldex Therapeutics USD -0.94 0.24 Jun/2026
Daiichi Sankyo JPY 37.72 11.03 Jun/2026
Eli Lilly USD 8.38 0.17 Jun/2026
Halozyme Therapeutics USD 2.28 0.68 Jun/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Intrexon USD -0.1 0.03 Jun/2024
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
Karyopharm Therapeutics USD -1.02 1.2 Mar/2026
Ligand Pharmaceuticals USD 2.37 0.74 Jun/2026
MacroGenics USD -0.58 0.36 Mar/2026
Neurocrine Biosciences USD 2.85 0.91 Jun/2026
Pfizer USD 0.77 0.02 Jun/2026
Regeneron Pharmaceuticals USD 14.29 4.82 Jun/2026
Rigel Pharmaceuticals USD 0.7 0.76 Sep/2024
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Ultragenyx Pharmaceutical USD -0.9 0.94 Jun/2026
Veracyte USD 0.54 0.02 Jun/2026